Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Anderson Raymond, Director. Officer active across 1 company, notably Monopar Therapeutics. In total, 14 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €301k. History available since 25 August 2026. The latest transaction was filed on 25 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Anderson Raymond is Administrateur at Monopar Therapeutics. He has filed 11 disclosures in total, and across the sampled recent filings the period runs from 2021-07-02 to 2024-01-03, with the modal transaction nature listed as Levée d'options.